首页 > 最新文献

Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA最新文献

英文 中文
[A new method for static intensity-modulated radiation therapy]. [静态调强放射治疗的新方法]。
Chao-min Chen, Lin-hong Zhou, Qing-wen Lü, Hao-yu Jin, Mu-tao Tang, Guang-jie Chen

Objective: To develop a new method for static intensity-modulated radiation therapy (IMRT) possible for implementation in smaller hospitals by incorporating accurate location equipments and treatment planning system in the available equipments for general radiotherapy.

Methods: Based on the techniques of conformal radiotherapy, a new split method for fabricating the three-dimensional physical compensator was developed to achieve IMRT.

Results: Experiment with the new method showed that the fabricated compensator could achieve good match between the high dosage shape in the target area and the dimensions of the tumor, and allowed adjustment of the dosage distribution according to the therapeutic requirement.

Conclusion: This simple and feasible method allows cost-effect application of IMRT in smaller hospitals.

目的:在现有的普通放射治疗设备中加入精确定位设备和治疗计划系统,开发一种适合小型医院实施的静态调强放射治疗新方法。方法:在适形放疗技术的基础上,提出了一种制作三维物理补偿器的新方法。结果:实验结果表明,所制备的补偿器能很好地匹配靶区的高剂量形状和肿瘤的尺寸,并能根据治疗需要调整剂量分布。结论:该方法简单可行,具有成本效益,可在小型医院应用。
{"title":"[A new method for static intensity-modulated radiation therapy].","authors":"Chao-min Chen,&nbsp;Lin-hong Zhou,&nbsp;Qing-wen Lü,&nbsp;Hao-yu Jin,&nbsp;Mu-tao Tang,&nbsp;Guang-jie Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To develop a new method for static intensity-modulated radiation therapy (IMRT) possible for implementation in smaller hospitals by incorporating accurate location equipments and treatment planning system in the available equipments for general radiotherapy.</p><p><strong>Methods: </strong>Based on the techniques of conformal radiotherapy, a new split method for fabricating the three-dimensional physical compensator was developed to achieve IMRT.</p><p><strong>Results: </strong>Experiment with the new method showed that the fabricated compensator could achieve good match between the high dosage shape in the target area and the dimensions of the tumor, and allowed adjustment of the dosage distribution according to the therapeutic requirement.</p><p><strong>Conclusion: </strong>This simple and feasible method allows cost-effect application of IMRT in smaller hospitals.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25751445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Liposome-mediated human CD40 gene transfection and human umbilical vein endothelial ECV-304 cells]. [脂质体介导的人CD40基因转染与人脐静脉内皮细胞ECV-304]。
Wei-rong Wang, Rong Lin, Yu-cong Yang, Wei-jie Gan, Jun-tian Liu, She-min Lü

Objective: To construct an eukaryotic expression vector containing human CD40 gene for its efficient, continuous and stable expression in human umbilical vein endothelial ECV-304 cells.

Methods: The recombinant plasmid pUCD40 was digested with endonucleases to obtain human CD40 gene fragment, which was cloned into pCDNA3.1 vector to construct recombinant eukaryotic expression vector pCDNA3.1(+)/CD40. The recombinant vector was identified by enzyme digestion before introduced into ECV-304 cells via liposome, with the positive cell clones selected with G418. The stable transfection and expression of CD40 in ECV-304 cells were identified by reverse transcription (RT)-PCR, Western blotting and flow cytometry, respectively.

Results: Enzyme digestion analysis showed that target gene had been cloned into the recombinant vector. The transfected ECV-304 cells successfully expressed human CD40 as determined by RT-PCR and Western-blotting, and 95% of the cells were CD40-positive as shown by flow cytometry.

Conclusion: The recombinant eukaryotic expression vector pCDNA3.1(+)/CD40 has been successfully constructed, which is capable of stable transfection and expression of CD40 in ECV-304 cells to facilitate further investigation of the roles of CD40 molecule in antiatherosclerotic drug development.

目的:构建含人CD40基因的真核表达载体,使其在人脐静脉内皮细胞ECV-304中高效、连续、稳定表达。方法:重组质粒pUCD40经酶切得到人CD40基因片段,将其克隆到pCDNA3.1载体中,构建重组真核表达载体pCDNA3.1(+)/CD40。重组载体经酶切鉴定后经脂质体导入ECV-304细胞,用G418筛选阳性克隆。通过逆转录-PCR、Western blotting和流式细胞术分别鉴定CD40在ECV-304细胞中的稳定转染和表达。结果:酶切分析表明目的基因已克隆到重组载体中。经RT-PCR和Western-blotting检测,转染后的ECV-304细胞成功表达了人CD40,流式细胞术检测显示95%的细胞CD40阳性。结论:成功构建了重组真核表达载体pCDNA3.1(+)/CD40,该载体能够在ECV-304细胞中稳定转染和表达CD40,为进一步研究CD40分子在抗动脉粥样硬化药物开发中的作用奠定了基础。
{"title":"[Liposome-mediated human CD40 gene transfection and human umbilical vein endothelial ECV-304 cells].","authors":"Wei-rong Wang,&nbsp;Rong Lin,&nbsp;Yu-cong Yang,&nbsp;Wei-jie Gan,&nbsp;Jun-tian Liu,&nbsp;She-min Lü","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To construct an eukaryotic expression vector containing human CD40 gene for its efficient, continuous and stable expression in human umbilical vein endothelial ECV-304 cells.</p><p><strong>Methods: </strong>The recombinant plasmid pUCD40 was digested with endonucleases to obtain human CD40 gene fragment, which was cloned into pCDNA3.1 vector to construct recombinant eukaryotic expression vector pCDNA3.1(+)/CD40. The recombinant vector was identified by enzyme digestion before introduced into ECV-304 cells via liposome, with the positive cell clones selected with G418. The stable transfection and expression of CD40 in ECV-304 cells were identified by reverse transcription (RT)-PCR, Western blotting and flow cytometry, respectively.</p><p><strong>Results: </strong>Enzyme digestion analysis showed that target gene had been cloned into the recombinant vector. The transfected ECV-304 cells successfully expressed human CD40 as determined by RT-PCR and Western-blotting, and 95% of the cells were CD40-positive as shown by flow cytometry.</p><p><strong>Conclusion: </strong>The recombinant eukaryotic expression vector pCDNA3.1(+)/CD40 has been successfully constructed, which is capable of stable transfection and expression of CD40 in ECV-304 cells to facilitate further investigation of the roles of CD40 molecule in antiatherosclerotic drug development.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25751520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion]. [bcl-2在小细胞肺癌中的表达:凋亡拮抗和免疫逃避的机制]。
Jun-meng Zheng, De-kun Wang, Hai-ming Jiang

Objective: To observe bcl-2 expression and its correlation with apoptosis antagonism and immune evasion of small cell lung cancer cell line and explore the application of bcl-2 antisense thio-oligonucleotide (bcl-2 SON) in gene therapy for lung cancer.

Methods: Western blotting was performed to detect bcl-2 expression in NCI-H69 cell line expressing Bcl-2 protein treated with bcl-2 SON. The treated NCI-H69 cells, along with the cells without bcl-2 SON treatment and NCI-H82 cells that did not express Bcl-2 protein, were respectively co-cultured with tumor-infiltrating lymphocytes (TILs) isolated from fresh tumor samples, and the apoptosis of the lung cancer cells was assessed by JAM assay.

Results: Western blotting revealed obvious inhibition of bcl-2 expression in NCI-H69 cells in response to bcl-2 SON treatment. JAM assay showed that the apoptosis of bcl-2 SON-treated H69 cells and NCI-H82 cells increased with the elevation of TIL ratio in the co-culture, while such changes were not observed in NCI-H69 cells without bcl-2 SON treatment.

Conclusion: Small cell lung cancer cells expressing bcl-2 may antagonize the antitumor immune attack in the host, and bcl-2 SON may provide an effective alternative in gene therapy for small cell lung cancer.

目的:观察小细胞肺癌细胞系bcl-2的表达及其与凋亡拮抗和免疫逃避的关系,探讨bcl-2反义硫代寡核苷酸(bcl-2 SON)在肺癌基因治疗中的应用。方法:采用Western blotting检测bcl-2在表达bcl-2蛋白的NCI-H69细胞株中表达情况。将经处理的NCI-H69细胞、未经bcl-2 SON处理的细胞和未表达bcl-2 SON的NCI-H82细胞分别与新鲜肿瘤样本中分离的肿瘤浸润淋巴细胞(til)共培养,采用JAM法检测肺癌细胞的凋亡情况。结果:Western blot结果显示,bcl-2 SON对NCI-H69细胞bcl-2表达有明显抑制作用。JAM实验显示,在共培养中,bcl-2 SON处理的H69细胞和NCI-H82细胞的凋亡随着TIL比例的升高而增加,而未处理bcl-2 SON的NCI-H69细胞则没有这种变化。结论:表达bcl-2的小细胞肺癌细胞可拮抗宿主体内的抗肿瘤免疫攻击,bcl-2 SON可能是小细胞肺癌基因治疗的有效替代方案。
{"title":"[bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion].","authors":"Jun-meng Zheng,&nbsp;De-kun Wang,&nbsp;Hai-ming Jiang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To observe bcl-2 expression and its correlation with apoptosis antagonism and immune evasion of small cell lung cancer cell line and explore the application of bcl-2 antisense thio-oligonucleotide (bcl-2 SON) in gene therapy for lung cancer.</p><p><strong>Methods: </strong>Western blotting was performed to detect bcl-2 expression in NCI-H69 cell line expressing Bcl-2 protein treated with bcl-2 SON. The treated NCI-H69 cells, along with the cells without bcl-2 SON treatment and NCI-H82 cells that did not express Bcl-2 protein, were respectively co-cultured with tumor-infiltrating lymphocytes (TILs) isolated from fresh tumor samples, and the apoptosis of the lung cancer cells was assessed by JAM assay.</p><p><strong>Results: </strong>Western blotting revealed obvious inhibition of bcl-2 expression in NCI-H69 cells in response to bcl-2 SON treatment. JAM assay showed that the apoptosis of bcl-2 SON-treated H69 cells and NCI-H82 cells increased with the elevation of TIL ratio in the co-culture, while such changes were not observed in NCI-H69 cells without bcl-2 SON treatment.</p><p><strong>Conclusion: </strong>Small cell lung cancer cells expressing bcl-2 may antagonize the antitumor immune attack in the host, and bcl-2 SON may provide an effective alternative in gene therapy for small cell lung cancer.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25756302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Apoptosis induced by curcumin and its effect on c-myc and caspase-3 expressions in human melanoma A375 cell line]. 姜黄素诱导人黑色素瘤A375细胞株凋亡及其对c-myc和caspase-3表达的影响
Shi Qiu, Sheng-shun Tan, Jiang-an Zhang, An Liu, Jing-yi Yuan, Guo-zhou Rao, Wen-yong Wang

Objective: To investigate the effect of curcumin on cell apoptosis and c-myc and caspase-3 expressions in human melanoma A375 cell line.

Methods: A375 cells were exposed to curcumin treatment and growth inhibition of the cells was examined by MTT assay. Annexin V/propidium iodide double staining and DNA fragmentation analysis were employed for assay of the cell apoptosis and morphological changes of the cells were observed with inverted microscopy and transmission electron microscopy, respectively. In situ hybridization and SABC immunohistochemistry were performed for detection of the expressions of c-Myc and caspase-3 in the A375 cells.

Results: Curcumin inhibited the growth of A375 cells in both time- and concentration-dependent manners. After treatment with 30 micromol/L curcumin for 48 h, apoptotic morphological changes were observed in the cells and an oligonucleosomal DNA ladder was clearly visualized in DNA fragmentation analysis. The apoptotic rates of the cells treated with curcumin at the concentration above 20 micromol/L were significantly higher than that of the control cells. c-myc expression level was decreased whereas caspase-3 expression increased with the increase in curcumin concentrations.

Conclusion: Curcumin can inhibit the proliferation and induce apoptosis of A375 cells in vitro, and the genes encoding c-myc and caspase-3 may play a role in the process.

目的:探讨姜黄素对人黑色素瘤A375细胞株细胞凋亡及c-myc和caspase-3表达的影响。方法:采用MTT法检测姜黄素对A375细胞的生长抑制作用。采用膜联蛋白V/碘化丙啶双染色法和DNA片段化法检测细胞凋亡情况,倒置显微镜和透射电镜观察细胞形态学变化。采用原位杂交和SABC免疫组化方法检测c-Myc和caspase-3在A375细胞中的表达。结果:姜黄素对A375细胞的生长具有时间依赖性和浓度依赖性。30微mol/L姜黄素作用48 h后,观察到细胞凋亡形态学改变,DNA片段化分析清晰可见寡核体DNA阶梯。姜黄素浓度大于20微mol/L时,细胞凋亡率显著高于对照细胞。随着姜黄素浓度的升高,C-myc表达水平降低,caspase-3表达水平升高。结论:姜黄素对体外培养的A375细胞具有抑制增殖和诱导凋亡的作用,其编码基因c-myc和caspase-3可能参与了这一过程。
{"title":"[Apoptosis induced by curcumin and its effect on c-myc and caspase-3 expressions in human melanoma A375 cell line].","authors":"Shi Qiu,&nbsp;Sheng-shun Tan,&nbsp;Jiang-an Zhang,&nbsp;An Liu,&nbsp;Jing-yi Yuan,&nbsp;Guo-zhou Rao,&nbsp;Wen-yong Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of curcumin on cell apoptosis and c-myc and caspase-3 expressions in human melanoma A375 cell line.</p><p><strong>Methods: </strong>A375 cells were exposed to curcumin treatment and growth inhibition of the cells was examined by MTT assay. Annexin V/propidium iodide double staining and DNA fragmentation analysis were employed for assay of the cell apoptosis and morphological changes of the cells were observed with inverted microscopy and transmission electron microscopy, respectively. In situ hybridization and SABC immunohistochemistry were performed for detection of the expressions of c-Myc and caspase-3 in the A375 cells.</p><p><strong>Results: </strong>Curcumin inhibited the growth of A375 cells in both time- and concentration-dependent manners. After treatment with 30 micromol/L curcumin for 48 h, apoptotic morphological changes were observed in the cells and an oligonucleosomal DNA ladder was clearly visualized in DNA fragmentation analysis. The apoptotic rates of the cells treated with curcumin at the concentration above 20 micromol/L were significantly higher than that of the control cells. c-myc expression level was decreased whereas caspase-3 expression increased with the increase in curcumin concentrations.</p><p><strong>Conclusion: </strong>Curcumin can inhibit the proliferation and induce apoptosis of A375 cells in vitro, and the genes encoding c-myc and caspase-3 may play a role in the process.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25756376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Report of 1 case of rare giant metastatic intra-ocular tumor]. 【罕见巨大转移性眼内肿瘤1例报告】。
Qiu-hong Liu, Yu-jian Zhan, Yang-gui Yu
{"title":"[Report of 1 case of rare giant metastatic intra-ocular tumor].","authors":"Qiu-hong Liu,&nbsp;Yu-jian Zhan,&nbsp;Yang-gui Yu","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25788291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expression of HLA-G protein in trophoblast cells]. 滋养细胞中HLA-G蛋白的表达。
Yan-qiu Wang, Shi-ling Chen, Fu-qi Xing

Objective: To investigate the expression of human leucocyte antigen protein G (HLA-G) in different trophoblast cells and different stages of pregnancy.

Methods: The expression of HLA-G protein in normal placenta and trophoblasts of different trimesters was detected using immunohistochemical method (SP).

Results: HLA-G protein expression exhibited spatio-temporal changes, which located in the extravillous trophoblast (EVT) and was higher in the placenta of the first and second trimesters while lower in the third trimester (P<0.01).

Conclusion: HLA-G protein expression in different stages of pregnancy and different trophoblasts may be related to the controlled invasion of the trophoblast.

目的:探讨人白细胞抗原蛋白G (HLA-G)在不同滋养细胞和妊娠不同阶段的表达情况。方法:采用免疫组化方法(SP)检测不同妊娠期正常胎盘和滋养细胞中HLA-G蛋白的表达。结果:HLA-G蛋白的表达呈现时空变化,其表达位点位于胎盘外滋养层(EVT),妊娠前、中期较高,妊娠晚期较低(p结论:HLA-G蛋白在妊娠不同阶段及不同滋养层的表达可能与滋养层侵袭受控制有关。
{"title":"[Expression of HLA-G protein in trophoblast cells].","authors":"Yan-qiu Wang,&nbsp;Shi-ling Chen,&nbsp;Fu-qi Xing","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the expression of human leucocyte antigen protein G (HLA-G) in different trophoblast cells and different stages of pregnancy.</p><p><strong>Methods: </strong>The expression of HLA-G protein in normal placenta and trophoblasts of different trimesters was detected using immunohistochemical method (SP).</p><p><strong>Results: </strong>HLA-G protein expression exhibited spatio-temporal changes, which located in the extravillous trophoblast (EVT) and was higher in the placenta of the first and second trimesters while lower in the third trimester (P<0.01).</p><p><strong>Conclusion: </strong>HLA-G protein expression in different stages of pregnancy and different trophoblasts may be related to the controlled invasion of the trophoblast.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25751443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selection of femoral prosthesis in total hip replacement for ankylosing spondylitis. 强直性脊柱炎全髋关节置换术中股骨假体的选择。
Pei Yang, Chun-sheng Wang, Kun-zheng Wang, Zhi-Bin Shi, Fu-liang Gong

Objective: To investigate the implication of morphological changes of the proximal femur in femoral prosthesis selection in total hip replacement for treatment of ankylosing spondylitis (AS).

Methods: Twenty-four patients (36 hips) admitted for cementless total hip replacement (THR) because of AS were enrolled in this study along with the control group of 30 patients (45 hips) without AS. Measurement of the Singh index, canal flare index, morphological index of the cortex, cortical index and stem-canal fit was performed in the two groups on the basis of roentgenograms.

Results: The AS patients had more serious osteoporosis in their proximal femur. There were significant differences between the two groups in Singh index, canal flare index, morphological index of the cortex and stem-canal fit (P<0.05), but not in the cortical index (P>0.05). The AS patients were found to have severe osteoporosis in the upper femur and massive spongy bone loss, so that the morphology of the canal was almost orthostatic in the upper femur because of the thinned femoral cortex.

Conclusion: Cemented prosthesis is recommended for AS patients with severe osteoporosis, who should be treated with revised THR to ensure good fit of the prosthesis to the canal. Cementless prosthesis, however, can still achieve good therapeutic effect in AS patients without significant morphologic changes in the proximal femurs. Computer-aided design and manufacture of individualized prosthesis better suits the AS patients than the currently available prosthesis.

目的:探讨强直性脊柱炎(AS)全髋关节置换术中股骨近端形态变化对股骨假体选择的影响。方法:24例(36髋)因AS接受无骨水泥全髋关节置换术(THR)的患者与30例(45髋)无AS的对照组一起纳入本研究。在x线平片的基础上测定两组的Singh指数、根管光照度指数、皮质形态学指数、皮质指数和茎管配合度。结果:AS患者股骨近端骨质疏松更为严重。两组间Singh指数、管径扩张指数、皮质形态指数和茎管配合度差异均有统计学意义(P0.05)。AS患者股骨上端骨质疏松严重,海绵骨质大量流失,由于股骨皮质变薄,股骨上端椎管形态几乎直立。结论:AS合并严重骨质疏松的患者推荐使用骨水泥假体,应采用改良的THR治疗,以保证假体与根管的良好贴合。然而,无骨水泥假体仍然可以在没有明显股骨近端形态学改变的AS患者中取得良好的治疗效果。计算机辅助设计和制造的个性化义肢比现有的义肢更适合AS患者。
{"title":"Selection of femoral prosthesis in total hip replacement for ankylosing spondylitis.","authors":"Pei Yang,&nbsp;Chun-sheng Wang,&nbsp;Kun-zheng Wang,&nbsp;Zhi-Bin Shi,&nbsp;Fu-liang Gong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the implication of morphological changes of the proximal femur in femoral prosthesis selection in total hip replacement for treatment of ankylosing spondylitis (AS).</p><p><strong>Methods: </strong>Twenty-four patients (36 hips) admitted for cementless total hip replacement (THR) because of AS were enrolled in this study along with the control group of 30 patients (45 hips) without AS. Measurement of the Singh index, canal flare index, morphological index of the cortex, cortical index and stem-canal fit was performed in the two groups on the basis of roentgenograms.</p><p><strong>Results: </strong>The AS patients had more serious osteoporosis in their proximal femur. There were significant differences between the two groups in Singh index, canal flare index, morphological index of the cortex and stem-canal fit (P<0.05), but not in the cortical index (P>0.05). The AS patients were found to have severe osteoporosis in the upper femur and massive spongy bone loss, so that the morphology of the canal was almost orthostatic in the upper femur because of the thinned femoral cortex.</p><p><strong>Conclusion: </strong>Cemented prosthesis is recommended for AS patients with severe osteoporosis, who should be treated with revised THR to ensure good fit of the prosthesis to the canal. Cementless prosthesis, however, can still achieve good therapeutic effect in AS patients without significant morphologic changes in the proximal femurs. Computer-aided design and manufacture of individualized prosthesis better suits the AS patients than the currently available prosthesis.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25751519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical nature of tetrodotoxin intoxication and the measures for emergency rescue]. 河豚毒素中毒的临床特点及急救措施
Gui-zhen Liu, Jia-lin Che, Ming Xiao, Zuo-hua Fan

Objective: To define the clinical nature of tetrodotoxin intoxication and explore the measures for its emergency rescue.

Methods: The emergency rescue measures and outcomes of 33 cases tetrodotoxin intoxication were reviewed.

Results: No obvious effects were observed in these patients after administration of atropine or application of respiratory stimulant, but implementation of mechanical ventilation and comprehensive life support measures resulted in successful rescue of mild to moderate cases within 10 to 14 h, and recovery of spontaneous respiration was achieved in critical cases in 19-24 h.

Conclusion: Tetrodotoxin selectively blocks the neuromuscular electrical activity, producing the effect of nondepolarizing curine and leading to failure of the respiratory drive without compromising the respiratory center. Atropine, a M-cholinergic receptor blocker, or central stimulants may fail to produce obvious effects, but comprehensive treatments including maintenance of effective ventilation can bring satisfactory effects.

目的:明确河豚毒素中毒的临床特点,探讨河豚毒素中毒的急救措施。方法:回顾性分析33例河豚毒素中毒的急救措施及救治结果。结果:这些患者在给予阿托品或应用呼吸刺激剂后均无明显效果,但实施机械通气和综合生命支持措施后,轻中度患者在10 ~ 14 h内抢救成功,危重患者在19 ~ 24 h内恢复自主呼吸。河豚毒素选择性地阻断神经肌肉电活动,产生非去极化曲线的效果,导致呼吸驱动的失败而不损害呼吸中枢。阿托品、m -胆碱能受体阻滞剂或中枢兴奋剂可能效果不明显,但包括维持有效通气在内的综合治疗可取得满意效果。
{"title":"[Clinical nature of tetrodotoxin intoxication and the measures for emergency rescue].","authors":"Gui-zhen Liu,&nbsp;Jia-lin Che,&nbsp;Ming Xiao,&nbsp;Zuo-hua Fan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To define the clinical nature of tetrodotoxin intoxication and explore the measures for its emergency rescue.</p><p><strong>Methods: </strong>The emergency rescue measures and outcomes of 33 cases tetrodotoxin intoxication were reviewed.</p><p><strong>Results: </strong>No obvious effects were observed in these patients after administration of atropine or application of respiratory stimulant, but implementation of mechanical ventilation and comprehensive life support measures resulted in successful rescue of mild to moderate cases within 10 to 14 h, and recovery of spontaneous respiration was achieved in critical cases in 19-24 h.</p><p><strong>Conclusion: </strong>Tetrodotoxin selectively blocks the neuromuscular electrical activity, producing the effect of nondepolarizing curine and leading to failure of the respiratory drive without compromising the respiratory center. Atropine, a M-cholinergic receptor blocker, or central stimulants may fail to produce obvious effects, but comprehensive treatments including maintenance of effective ventilation can bring satisfactory effects.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25756298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Therapeutic effect of TAX combined with Herceptin or epirubicin against breast cancer positive for Her-2/neu]. [TAX联合赫赛汀或表柔比星治疗Her-2/neu阳性乳腺癌的疗效]。
Fei Cui, Rong-cheng Luo, Jin-zhang Chen, Bin Chen, Yu-xian Huang

Objective: To compare the therapeutic effects of biochemotherapy regimen with Herceptin plus taxol (TAX) and the chemotherapy regimen with epirubicin plus TAX against Her-2/neu-positive breast cancer and observe the changes in serum tumor markers in patients receiving biochemotherapy.

Methods: Seventy-three patients with advanced breast cancer positive for Her-2/neu as revealed by immunohistochemistry were divided into the study group (n=32) to receive treatment with the regimen of Herceptin plus TAX and control group (n=41) with the regimen of epirubicin(EPI) plus TAX. The therapeutic effects of the regimens were observed and in the study group, the relationship of the therapeutic effect with Her-2/neu positivity and changes in serum tumor markers were examined.

Results: The objective response rate and clinical benefit response rate were obviously higher in the study group than in the control group. In the study group, the clinical response rate of patients with positive immunostaining for Her-2/neu of grades 1+, 2+ and 3+ were 0%, 44.4% and 63.6%, respectively, as compared with those in the control group of 8.3%, 36.4%, and 38.9%, respectively, and the treatment resulted in lowered levels of serum tumor markers without significant changes in CA153, tps and CEA (P<0.05) after treatment, but CA125 showed no significant difference (P>0.05).

Conclusions: In patients with advanced breast cancer with positive immunostaining for Her-2/neu of grade 3+, the regimen of Herceptin plus TAX can be more effective than the chemotherapeutic regimen of EPI plus TAX. Patients with Her-2/neu (+++) benefit more from the treatment than those with Her-2/neu (++). Serum CEA, CA153 and TPS levels also possess some value in evaluating the therapeutic effects of the regimens.

目的:比较赫赛汀加紫杉醇(TAX)化疗方案与表柔比星加TAX化疗方案对Her-2/新阳性乳腺癌的治疗效果,并观察化疗患者血清肿瘤标志物的变化。方法:经免疫组化检查Her-2/neu阳性的晚期乳腺癌患者73例,分为研究组(n=32)采用赫赛汀+ TAX方案,对照组(n=41)采用表柔比星(EPI) + TAX方案。观察各治疗方案的治疗效果,并在研究组中检测Her-2/neu阳性及血清肿瘤标志物变化与治疗效果的关系。结果:研究组客观有效率和临床获益有效率均明显高于对照组。研究组Her-2/neu 1+、2+、3+级免疫染色阳性患者的临床有效率分别为0%、44.4%、63.6%,对照组的临床有效率分别为8.3%、36.4%、38.9%,治疗后血清肿瘤标志物水平降低,CA153、tps、CEA无明显变化(P0.05)。结论:在Her-2/neu 3+级免疫染色阳性的晚期乳腺癌患者中,赫赛汀+ TAX方案比EPI + TAX化疗方案更有效。Her-2/neu(+++)患者比Her-2/neu(++)患者从治疗中获益更多。血清CEA、CA153和TPS水平对评价治疗效果也有一定的价值。
{"title":"[Therapeutic effect of TAX combined with Herceptin or epirubicin against breast cancer positive for Her-2/neu].","authors":"Fei Cui,&nbsp;Rong-cheng Luo,&nbsp;Jin-zhang Chen,&nbsp;Bin Chen,&nbsp;Yu-xian Huang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To compare the therapeutic effects of biochemotherapy regimen with Herceptin plus taxol (TAX) and the chemotherapy regimen with epirubicin plus TAX against Her-2/neu-positive breast cancer and observe the changes in serum tumor markers in patients receiving biochemotherapy.</p><p><strong>Methods: </strong>Seventy-three patients with advanced breast cancer positive for Her-2/neu as revealed by immunohistochemistry were divided into the study group (n=32) to receive treatment with the regimen of Herceptin plus TAX and control group (n=41) with the regimen of epirubicin(EPI) plus TAX. The therapeutic effects of the regimens were observed and in the study group, the relationship of the therapeutic effect with Her-2/neu positivity and changes in serum tumor markers were examined.</p><p><strong>Results: </strong>The objective response rate and clinical benefit response rate were obviously higher in the study group than in the control group. In the study group, the clinical response rate of patients with positive immunostaining for Her-2/neu of grades 1+, 2+ and 3+ were 0%, 44.4% and 63.6%, respectively, as compared with those in the control group of 8.3%, 36.4%, and 38.9%, respectively, and the treatment resulted in lowered levels of serum tumor markers without significant changes in CA153, tps and CEA (P<0.05) after treatment, but CA125 showed no significant difference (P>0.05).</p><p><strong>Conclusions: </strong>In patients with advanced breast cancer with positive immunostaining for Her-2/neu of grade 3+, the regimen of Herceptin plus TAX can be more effective than the chemotherapeutic regimen of EPI plus TAX. Patients with Her-2/neu (+++) benefit more from the treatment than those with Her-2/neu (++). Serum CEA, CA153 and TPS levels also possess some value in evaluating the therapeutic effects of the regimens.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25756301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Surgical treatment of anterior circulation aneurysm via pterion keyhole approach]. [翼点锁孔入路治疗前循环动脉瘤]。
Wen-feng Feng, Song-tao Qi, Sheng-ping Huang, Li-jin Huang

Objective: To investigate the feasibility of pterion keyhole approach with minimal invasion for treatment of the anterior circulation aneurysm.

Method: Aneurysm clipping through the pterion keyhole approach was performed in patients with anterior circulation aneurysms, including 9 with posterior communication artery aneurysms, 3 with middle cerebral artery aneurysms and 6 with anterior communication artery aneurysms, who were in stages I to III according to Hunt-Hess scale.

Result: All the aneurysms were clipped successfully. One patient with a left posterior communication artery aneurysm developed transient sensory aphasia and motor aphasia after surgery due to intraoperative aneurysm rupture. No facial paralysis occurred due to damage of the facial nerve.

Conclusion: The pterion keyhole approach is a very useful surgical approach for treatment of anterior circulation aneurysms on the basis of cautious determination of indications and careful operation planning.

目的:探讨微创翼点锁孔入路治疗前循环动脉瘤的可行性。方法:对前循环动脉瘤患者行点锁孔入路夹闭动脉瘤,其中9例为后交通动脉瘤,3例为大脑中动脉瘤,6例为前交通动脉瘤,按Hunt-Hess分级分为I ~ III期。结果:所有动脉瘤均成功夹闭。1例左侧后交通动脉瘤患者因术中动脉瘤破裂,术后出现短暂性感觉失语和运动失语。无面神经损伤引起面瘫。结论:翼点锁孔入路是治疗前循环动脉瘤的一种非常有效的手术入路,应谨慎确定适应证和周密的手术计划。
{"title":"[Surgical treatment of anterior circulation aneurysm via pterion keyhole approach].","authors":"Wen-feng Feng,&nbsp;Song-tao Qi,&nbsp;Sheng-ping Huang,&nbsp;Li-jin Huang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the feasibility of pterion keyhole approach with minimal invasion for treatment of the anterior circulation aneurysm.</p><p><strong>Method: </strong>Aneurysm clipping through the pterion keyhole approach was performed in patients with anterior circulation aneurysms, including 9 with posterior communication artery aneurysms, 3 with middle cerebral artery aneurysms and 6 with anterior communication artery aneurysms, who were in stages I to III according to Hunt-Hess scale.</p><p><strong>Result: </strong>All the aneurysms were clipped successfully. One patient with a left posterior communication artery aneurysm developed transient sensory aphasia and motor aphasia after surgery due to intraoperative aneurysm rupture. No facial paralysis occurred due to damage of the facial nerve.</p><p><strong>Conclusion: </strong>The pterion keyhole approach is a very useful surgical approach for treatment of anterior circulation aneurysms on the basis of cautious determination of indications and careful operation planning.</p>","PeriodicalId":11097,"journal":{"name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25756305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1